LINC02697

Across TCGA pan-cancer cohorts, LINC02697 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC02697 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC02697 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02697 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

MESO, KIRC, and LIHC are the cancer types where LINC02697 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.277	0.586	<.001	99	view →
KIRC	OS	Tertile	All	0.480	0.669	<.001	94	view →
LIHC	OS	Tertile	All	0.465	0.721	<.001	90	view →
STAD	DFS	Tertile	II,III,IV	0.389	0.557	.009	87	view →
GBM	DFS	Median	All	0.178	0.326	<.001	47	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
LUAD	OS	Quartile	III,IV	0.245	0.589	<.001	36	view →
UCEC	DFS	Tertile	IV	0.283	0.719	.024	36	view →
BLCA	DFS	Tertile	All	0.514	0.633	.017	21	view →
LAML	DFS	Tertile	All	0.081	0.572	.005	18	view →
CHOL	DFS	Tertile	III,IV	0.133	0.779	.038	15	view →
THYM	DFS	Tertile	II,III,IV	0.259	0.789	.024	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC02697–MESO (OS)

Open the MESO breakdown →